Relationship between tumor response with outcomes in EGFR mutation positive (M+) non-small cell lung cancer (NSCLC) treated with tyrosine-kinase inhibitors (TKI)

Autor:	Bibhas Chakraborty, Kiat Hon Lim, Wan-Teck Lim, Angela Takano, Amit Jain, Wu Meng Tan, Wei Chong Tan, Mei-Kim Ang, Chee Keong Toh, Daniel Shao-Weng Tan, Q.S. Ng, Ravindran Kanesvaran, Sylvaine Barbier, Eng Huat Tan
Rok vydání:	2014
Předmět:	Cancer Research Pathology medicine.medical_specialty business.industry Mutant non-small cell lung cancer (NSCLC) Tumor response Tumour response medicine.disease Oncology Egfr mutation medicine Cancer research business Tyrosine kinase
Zdroj:	Journal of Clinical Oncology. 32:e19101-e19101
ISSN:	1527-7755 0732-183X
Popis:	e19101 Background: The relationship between RECIST tumour measurements and clinical outcomes in EGFR mutant NSCLC is not well established. We sought to identify tumour response parameters that corr...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::25e4cf3f3d0aa6f260a030412ef9ab4f https://doi.org/10.1200/jco.2014.32.15_suppl.e19101 Zobrazit plný text záznamu